HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Colgate-Palmolive

This article was originally published in The Rose Sheet

Executive Summary

Colgate-Palmolive: Lady Speed Stick Invisible Dry antiperspirant provides consumers "protection in a stick without leaving a white residue" while offering the same odor protection benefits as the original Lady Speed Stick, the company said. Supported by a $10 mil. ad campaign and $5 mil. in promotional activities, Invisible Dry is positioned as a "no-white residue" antiperspirant without the "sticky" and "less effective" aspects of the popular clear antiperspirant/deodorant offerings. Print and TV ads designed by New York City-based Young & Rubicam will run January-September. Promotions include couponing and sampling beginning in December. On-counter in October, a 1.4 oz. Invisible Dry stick is available in Shower Fresh, Powder Fresh, Scented and Unscented formulas and costs about $1.79...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel